Hadassah

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Monday, Nov 14 2016

Prof. Ruth Gabizon with neurology research colleagues.

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

Called GranaGard™, the supplement is a submicron Pomegranate Seed Oil (PSO) emulsion, and is an innovative formulation of one of the strongest natural antioxidants, Punicic acid (an Omega 5 lipid). The patented formulation has been shown to delay disease onset and prevent neuronal death in a model of genetic prion disease (a neurodegenerative disease caused by a mutation that leads to misfolded prion proteins which, in turn, kill off normal brain cells). The formulation also has been shown to reduce disease burden in a mouse model of Multiple Sclerosis. In both models, there was no evidence of toxicity after long-term administration.

As Prof. Gabizon explains: "Reactive oxygen species (ROS) are chemically active molecules that can lead to significant damage to cells, particularly in the central nervous system (CNS). It is therefore widely accepted that this chemical agent contributes to chronic inflammation and neurodegenerative diseases. While antioxidants that can counteract ROS are ubiquitously present in a healthy human diet, their activity is limited by chemical degradation, poor bioavailability, reduced distribution to the CNS, and sub-pharmacological doses.”

To overcome these limitations, Prof. Gabizon relates, she and her research team created GranaGard. “In addition to its protective role in subjects at risk of developing neurodegenerative conditions,” she says, “GranaGard is expected to be effective for general neurological well-being for the larger public.” 

Company spokespeople explain that the PSO submicron droplets have the advantage that the nanoformulation may avoid the first passage of the oil through the liver, thereby enhancing the availability of the droplets to other organs such as the CNS where it is then able to enter the brain and protect membrane lipids from ROS attacks that occur as a result of both every-day efforts and pathological events.

Granalix BioTechnologies focuses on developing science-based novel formulations of natural antioxidants that can be used to prevent and treat neurodegenerative conditions. The Company was established in 2014 by Prof. Gabizon and Prof. Shlomo Magdassi of the Casali Center for Applied Chemistry, the Institute of Chemistry, and the Center for Nanoscience and Nanotechnology at the Hebrew University. It is a spinoff of the Hebrew University’s technology transfer company, Yissum, and Hadasit, Hadassah’s technology transfer company.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Feb 15 2018

First Cadre of Arab-Sector “Heart Guardians” Graduated by Hadassah

The first cadre of Jerusalem’s Arab-sector volunteer “Heart Guardians” received graduation certificates at Hadassah Hospital Ein Kerem today, from the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women, recognizing their leadership in bringing better health to their local community.

READ MORE ›
alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More